A Leading Multinational Growth Pharma
A leading multinational growth pharma, with several M&As in the past, disparate 77+ systems and 18 data sources across 36 countries and 3 regions, had no single source of truth of their customers. As a result, their commercial team had to deal with a lot of duplicates, leading to inefficient marketing campaigns and ineffective sales activities. They needed to modernize and standardize their global business intelligence (BI) reporting platform and build digital capabilities in the non-rep channels by offering insights on-demand and supporting 24x7 business operations. In addition, they had no control over healthcare providers (HCP) consent information and were required to meet Global Data Protection Regulation (GDPR) compliance by managing ‘Consent to Market’ from their EMEA based HCPs.
Their Commercial Intelligence team utilized Reltio’s Self-Learning Data Platform to achieve this ambitious goal. With flexible modern data architecture and agile deployment the solution went live globally in 26 weeks. It helped them bring together healthcare providers (HCP), healthcare organizations (HCO), key opinion leaders (KOL), affiliations, CRM, payer, plan, pricing, contracting, transaction, compliance, product, and digital data to build a Healthcare Information Management Data Hub on top of Reltio Self-Learning Data Platform.
As a result they were able to to manage consents and affiliations to run their day to day commercial operations and go-to-market activities without worrying about GDPR and other compliance requirements. In addition, Reltio IQ helped them deliver contextual and relevant insights for better business outcomes to their sales reps, campaign managers, field managers, country managers, and commercial team. For example, when a new drug was launched, they were able to track sales performance compared to projections so that they could adjust strategies whenever needed.